A multidisciplinary group of specialists was assembled by a medical marketing company (MediMark International) with an unrestricted educational grant from Aventis Pharma. The taskforce members included:

Poster Abstracts Falk Foundation Dr. Falk Pharma Falk Symposium 199 Highlights from Hepatology 2015: From Chronic Hepatitis to Hepatocellular Carcinoma October 14 – 15, 2015 Konzerthaus Freiburg

Areport published last week on “the influence of the pharmaceutical industry” describes a strong United Kingdom pharmaceutical industry, whose net exports are worth over £3bn ($5.6bn; €4.3bn) annually. The industry’s declared goal is “to bring patients life-enhancing medicines,” a goal “not only necessary but noble.” The House of Commons health committee examined the means used to achieve this ...

Challenging pharmaceutical manufacturers everywhere, every day are the myriad issues surrounding the acquisition, disposition and analysis of the huge amounts of data their operations create around the clock. Any Pharma producer worth its salt these days is likely investing a great deal of time, resources and effort to create or maintain a comprehensive information technology (IT) infrastructur...

The life sciences are transforming pharmaceutical companies in terms of both internal R&D processes and strategies for external knowledge capture mergers, acquisitions, strategic alliances and licensing. Dr. Mittra’s research on life science innovation and the pharmaceutical industry reveals that these are a cluster of related activities that provide various strategic options for managing innov...